Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2015
HIV-1 Reverse Transcriptase-Based Assay to Determine Cellular dNTP ConcentrationsJoseph A Hollenbaugh, Baek KimJournal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumorJoseph A Hollenbaugh, Richard W DuttonVirology|May 14, 2011
Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysisJoseph A Hollenbaugh, Joshua Munger, Baek KimThe Journal of Biological Chemistry|May 17, 2012
Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophagesBaek Kim, Laura A Nguyen, Waaqo Daddacha, et al.Plos One|July 19, 2011
Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 TatYuri Kim, Joseph A Hollenbaugh, Dong-Hyun Kim, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysisJoseph A Hollenbaugh, Joyce Reome, Mark Dobrzanski, et al.Addiction Biology|November 29, 2023
Fentanyl-induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 monthsJeffrey D Benner, Steven M Cohen, Joseph A Hollenbaugh, et al.Plos One|November 29, 2012
Pleckstrin homology domain of Akt kinase: a proof of principle for highly specific and effective non-enzymatic anti-cancer targetEun-Ha Joh, Joseph A Hollenbaugh, Baek Kim, et al.Virology|August 31, 2015
Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cellsJoseph A Hollenbaugh, Susan M Schader, Raymond F Schinazi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responsesMark J Dobrzanski, Joyce B Reome, Joseph A Hollenbaugh, et al.Pageof 3